Simon_Campbell

Simon Campbell

Simon Campbell

British chemist


Sir Simon Fraser Campbell, CBE, FRS, FMedSci (born 27 March 1941) is a British chemist.[1]

Quick Facts Born, Alma mater ...

Early life and education

Campbell was born on 27 March 1941 in Lapal, England.[3] He obtained a first-class BSc degree in Chemistry in 1962, a PhD degree in 1965, and an honorary DSc degree in 2004 from the University of Birmingham .

Career

He was President of the Royal Society of Chemistry from 2004 to 2006.[1] He led innovative research, discovering some of the world's best-selling prescription drugs, including sildenafil, amlodipine, and doxazosin.[4] He was visiting lecturer at Universidade de São Paulo.[citation needed] He was a medicinal chemist for Pfizer.[5] He was visiting professor at University of Leeds, and on the advisory board of University of Kent, and University of Bristol.[6]

Awards and honours

Campbell was knighted in the 2015 New Year Honours for services to chemistry,[7][8] having previously been made a Commander of the Order of the British Empire (CBE).


References

  1. Campbell, S (2006). "Simon Campbell CBE, FMed Sci, FRS. Interview by Joanna Owens". Nature Reviews Drug Discovery. 5 (8): 626. doi:10.1038/nrd2116. PMID 16918018. S2CID 38734548.
  2. "SIMON FRASER CAMPBELL (Director) :: OpenCorporates". Archived from the original on 1 January 2015. Retrieved 1 January 2015.
  3. "Dr Simon Campbell receives CBE at Buckingham Palace". Royal Society of Chemistry. 14 December 2006. Retrieved 14 January 2023.
  4. Simon Campbell C.B.E F.R.S Ph.D. "Astex Therapeutics Limited: Private Company Information - BusinessWeek". Investing.businessweek.com. Retrieved 1 December 2011.[dead link]
  5. "No. 61092". The London Gazette (Supplement). 31 December 2014. p. N2.

Share this article:

This article uses material from the Wikipedia article Simon_Campbell, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.